↓ Skip to main content

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, January 2005
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
147 Dimensions

Readers on

mendeley
50 Mendeley
Title
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
Published in
Breast Cancer Research and Treatment, January 2005
DOI 10.1007/s10549-004-1720-2
Pubmed ID
Authors

Gunter von Minckwitz, Walter Jonat, Peter Fasching, Andreas du Bois, Ulrich Kleeberg, Hans-Joachim Lück, Erika Kettner, Jörn Hilfrich, Wolfgang Eiermann, Julie Torode, Andreas Schneeweiss

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 26%
Student > Ph. D. Student 9 18%
Professor 4 8%
Student > Master 4 8%
Student > Postgraduate 3 6%
Other 5 10%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 10 20%
Biochemistry, Genetics and Molecular Biology 7 14%
Agricultural and Biological Sciences 6 12%
Chemistry 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Other 7 14%
Unknown 13 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2009.
All research outputs
#7,535,755
of 22,992,311 outputs
Outputs from Breast Cancer Research and Treatment
#1,674
of 4,677 outputs
Outputs of similar age
#36,247
of 140,254 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#5
of 14 outputs
Altmetric has tracked 22,992,311 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.